{"schema_version":"secwatch.filing_event.v1","accession":"0001639691-22-000098","form_type":"8-K","ticker":"LIVN","cik":"0001639691","company_name":"LivaNova PLC","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.529532+00:00","generated_at":"2026-06-22T14:15:03.397975+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"LivaNova Reports Third-Quarter 2022 Results with Revenue of $252.6M","bullets":["Revenue of $252.6M decreased 0.2% reported but increased 5.2% on constant-currency basis vs prior year.","GAAP diluted loss per share of $2.01 includes non-cash goodwill impairment of ~$2.40 per share; adjusted diluted EPS was $0.58.","Michael Hutchinson named Senior Vice President, Chief Legal Officer and Company Secretary, succeeding Keyna Skeffington.","Full-year 2022 outlook unchanged; focus on core growth drivers, clinical pipeline, and cash generation."],"urls":{"canonical":"https://secwatch.observer/filing/0001639691-22-000098","json":"https://secwatch.observer/filing/0001639691-22-000098.json","markdown":"https://secwatch.observer/filing/0001639691-22-000098.md","text":"https://secwatch.observer/filing/0001639691-22-000098.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1639691/000163969122000098/0001639691-22-000098-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1639691/000163969122000098/livn-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T14:15:03.397975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"add6e94b02045db088feffee5af7960c03e6a2a2","claim":"LivaNova PLC reported the quarter ended September 30, 2022 results: revenue $252.6 million, EPS $2.01. Guidance reaffirmed.","evidence_excerpt":"Revenue of $252.6 million for the quarter decreased 0.2 percent on a reported basis and increased 5.2 percent on a constant-currency basis, as compared to the prior-year period • U.S. GAAP diluted loss per share was $2.01, including a non-cash goodwill impairment charge of approximately $2.40 per share, and adjusted diluted earnings per share was $0.58","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1639691/000163969122000098/0001639691-22-000098-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$252.6 million"},{"label":"EPS","value":"$2.01"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}